2017 GPOH guidelines for diagnosis and treatment of patients with neuroblastic tumors

Tools

Item Type:	Article
Title:	2017 GPOH guidelines for diagnosis and treatment of patients with neuroblastic tumors
Creators Name:	Simon, T., Hero, B., Schulte, J.H., Deubzer, H., Hundsdoerfer, P., von Schweinitz, D., Fuchs, J., Schmidt, M., Prasad, V., Krug, B., Timmermann, B., Leuschner, I., Fischer, M., Langer, T., Astrahantseff, K., Berthold, F., Lode, H. and Eggert, A.
Abstract:	The clinical course of neuroblastoma is more heterogeneous than any other malignant disease. Most low-risk patients experience regression after limited or even no chemotherapy. However, more than half of high-risk patients die from disease despite intensive multimodal treatment. Precise patient characterization at diagnosis is key for risk-adapted treatment. The guidelines presented here incorporate results from national and international clinical trials to produce recommendations for diagnosing and treating neuroblastoma patients in German hospitals outside of clinical trials.
Keywords:	Neuroblastoma, Ganglioneuroma, Childhood Cancer, Treatment Recommendations
Source:	Klinische Padiatrie
ISSN:	0300-8630
Publisher:	Thieme
Volume:	229
Number:	3
Page Range:	147-167
Date:	May 2017
Official Publication:	https://doi.org/10.1055/s-0043-103086
PubMed:	View item in PubMed

Repository Staff Only: item control page